These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18803402)

  • 21. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C.
    Chandra M; Dong WJ; Pan BS; Cheung HC; Solaro RJ
    Biochemistry; 1997 Oct; 36(43):13305-11. PubMed ID: 9341222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural mapping of single cysteine mutants of cardiac troponin I.
    Dong WJ; Xing J; Chandra M; Solaro J; Cheung HC
    Proteins; 2000 Dec; 41(4):438-47. PubMed ID: 11056032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides.
    Sorsa T; Pollesello P; Permi P; Drakenberg T; Kilpeläinen I
    J Mol Cell Cardiol; 2003 Sep; 35(9):1055-61. PubMed ID: 12967628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation-dependent conformational transition of the cardiac specific N-extension of troponin I in cardiac troponin.
    Howarth JW; Meller J; Solaro RJ; Trewhella J; Rosevear PR
    J Mol Biol; 2007 Oct; 373(3):706-22. PubMed ID: 17854829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping contacts between regulatory domains of skeletal muscle TnC and TnI by analyses of single-chain chimeras.
    Tiroli AO; Tasic L; Oliveira CL; Bloch C; Torriani I; Farah CS; Ramos CH
    FEBS J; 2005 Feb; 272(3):779-90. PubMed ID: 15670158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation.
    Biesiadecki BJ; Kobayashi T; Walker JS; Solaro RJ; de Tombe PP
    Circ Res; 2007 May; 100(10):1486-93. PubMed ID: 17446435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and interaction site of the regulatory domain of troponin-C when complexed with the 96-148 region of troponin-I.
    McKay RT; Pearlstone JR; Corson DC; Gagné SM; Smillie LB; Sykes BD
    Biochemistry; 1998 Sep; 37(36):12419-30. PubMed ID: 9730814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining the region of troponin-I that binds to troponin-C.
    McKay RT; Tripet BP; Pearlstone JR; Smillie LB; Sykes BD
    Biochemistry; 1999 Apr; 38(17):5478-89. PubMed ID: 10220335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C.
    Lindhout DA; Li MX; Schieve D; Sykes BD
    Biochemistry; 2002 Jun; 41(23):7267-74. PubMed ID: 12044157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Effects of cTnC DCM Mutations on Calcium Sensitivity and Myofilament Activation-An Integrated Multiscale Modeling Study.
    Dewan S; McCabe KJ; Regnier M; McCulloch AD; Lindert S
    J Phys Chem B; 2016 Aug; 120(33):8264-75. PubMed ID: 27133568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle.
    Dyer EC; Jacques AM; Hoskins AC; Ward DG; Gallon CE; Messer AE; Kaski JP; Burch M; Kentish JC; Marston SB
    Circ Heart Fail; 2009 Sep; 2(5):456-64. PubMed ID: 19808376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of regions of troponin I important in deactivation of cardiac myofilaments by acidic pH.
    Li G; Martin AF; Solaro RJ
    J Mol Cell Cardiol; 2001 Jul; 33(7):1309-20. PubMed ID: 11437537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy.
    Yumoto F; Lu QW; Morimoto S; Tanaka H; Kono N; Nagata K; Ojima T; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Nishita K; Tanokura M; Ohtsuki I
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1519-26. PubMed ID: 16288990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NMR structure of a bifunctional rhodamine labeled N-domain of troponin C complexed with the regulatory "switch" peptide from troponin I: implications for in situ fluorescence studies in muscle fibers.
    Mercier P; Ferguson RE; Irving M; Corrie JE; Trentham DR; Sykes BD
    Biochemistry; 2003 Apr; 42(15):4333-48. PubMed ID: 12693929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMR and mutagenesis studies on the phosphorylation region of human cardiac troponin I.
    Ward DG; Brewer SM; Gallon CE; Gao Y; Levine BA; Trayer IP
    Biochemistry; 2004 May; 43(19):5772-81. PubMed ID: 15134451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The miscommunicative cardiac cell: when good proteins go bad.
    Gomes AV; Venkatraman G; Potter JD
    Ann N Y Acad Sci; 2005 Jun; 1047():30-7. PubMed ID: 16093482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the structural domain of troponin C in muscle regulation: NMR studies of Ca2+ binding and subsequent interactions with regions 1-40 and 96-115 of troponin I.
    Mercier P; Li MX; Sykes BD
    Biochemistry; 2000 Mar; 39(11):2902-11. PubMed ID: 10715110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-linking study of the N-terminal extension of human cardiac troponin I.
    Ward DG; Brewer SM; Cornes MP; Trayer IP
    Biochemistry; 2003 Sep; 42(34):10324-32. PubMed ID: 12939162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.